Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hesperos Inc. provides advanced human-on-a-chip technology as a service to accelerate drug discovery/development. Their patented multi-organ microphysiological systems allow pharmaceutical companies to test compound safety/efficacy in interconnected human cell-based models. Their technology has been validated by regulatory acceptance—data from their system enabled an IND application that led directly to a Phase II clinical trial without animal data. They serve pharma/biotech/cosmetic/government clients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hesperos Inc..